- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
CMS Picks 73 for Innovation Advisors Program
The advisers come from 27 states and Washington, D.C. and compose a group that includes clinicians, allied health professionals and health administrators. They will participate in an orientation program and then work with the CMS Innovation Center to test new care models aimed at improving quality and lowering costs. They're also expected to create partnerships to develop new ideas and then share those ideas regionally and nationwide.
Representatives from Providence Health & Services, SSM Healthcare in Wisconsin, and the University of Pittsburgh Medical Center were among those chosen.
Read the full story at: http://tinyurl.com/7534vas
Read the CMS press release at: http://www.cms.gov/apps/media/press/factsheet.asp?Counter=4240
Sources: Kaiser Health News; Modern Healthcare; CMS
Selecting from a pool of more than 900 applications, the Centers for Medicare & Medicaid Services (CMS) has chosen 73 healthcare professionals for the agency's Innovation Advisors Program, an initiative in which trained leaders will test new delivery models in their organizations and communities.
Understanding How Fitness Affects Digestive Diseases
April 18th 2025Exercise is a powerful modulator of gut health in patients with gastrointestinal (GI) conditions, as moderate activity can ease gut inflammation, reduce colorectal cancer risk, and relieve constipation, while intense workouts may backfire, causing reflux, GI bleeding, or gut barrier disruption.
Read More
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Key Indicators of Myasthenia Gravis Disease Progression Reduced With Efgartigimod
April 18th 2025Research presented at the recent annual meeting of the Academy of Managed Care Pharmacy highlights outcomes among patients who have anti-acetylcholine receptor antibody-positive myasthenia gravis that include reduced exacerbations and need for immunoglobulin.
Read More
